EquityZen Growth Technology Fund LLC - Series 2337
Raised
$10M
Investors
24
Min Invest
$50,050
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2337 is a Delaware-organized pooled investment fund filed by EquityZen Advisors and Philip Haslett on July 20, 2026. The fund raised $10.1M from 24 investors with a $50K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This entity is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption structure common to private secondary market platforms, with a $50K minimum positioning it for accredited individual investors. The raise size and investor count align with typical EquityZen series vehicles facilitating access to late-stage private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
